Dr. Iacoboni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3006 S Maryland Pkwy
Ste 205
Las Vegas, NV 89109Phone+1 702-735-7154Fax+1 702-735-7153
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1982 - 1984
Medical University of South CarolinaResidency, Internal Medicine, 1979 - 1982
University of California San Francisco School of MedicineClass of 1979
Certifications & Licensure
CA State Medical License 1985 - Present
AZ State Medical License 2014 - 2027
CO State Medical License 1984 - 2025
ID State Medical License 2001 - 2025
NV State Medical License 2014 - 2025
OR State Medical License 2016 - 2025
WA State Medical License 1986 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- 117 citationsPhase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemiaHagop M. Kantarjian, Elihu H. Estey, William Plunkett, Michael J. Keating, Ronald S. Walters
The American Journal of Medicine. 1986-09-01 - 68 citationsHigh-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis.Stephen Iacoboni, William Plunkett, Hagop M. Kantarjian, E. Estey, Michael J. Keating
Journal of Clinical Oncology. 1986-07-01 - 18 citationsComparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in pat...L Danhauser, William Plunkett, J Liliemark, Varsha Gandhi, S. Iacoboni
Leukemia. 1987-09-01
Press Mentions
A Different POV: Improve Your Cancer Treatment Plan by Understanding Oncologists’ Perspectives with Dr. Stephen IacoboniJune 8th, 2022
Press Release: Good Shepherd Welcomes Oncology & Hematology SpecialistFebruary 11th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
